PSM/SH2B1 splice variants: Critical role in Src catalytic activation and the resulting STAT3-mediated mitogenic response

Journal of Cellular Biochemistry

Volumn 104, Issue 1, 2008, Pages 105-118

  Zhang, Manchao ^a   Deng, Youping ^b   Riedel, Heimo ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b The University of Southern Mississippi   (United States)

Author keywords

Cell permeant peptide; Mitogenesis; PH; Phenotypic cell transformation; Pro rich; SH2; SH2 B; Survival

Indexed keywords

ADENOSINE TRIPHOSPHATE; HERBIMYCIN; MUTANT PROTEIN; PROTEIN SH2; PROTEIN SH2B1; PROTEIN TYROSINE KINASE; STAT3 PROTEIN; UNCLASSIFIED DRUG; DROSOPHILA PROTEIN; GLUTAMATE CARBOXYPEPTIDASE II; GLUTAMATE CARBOXYPEPTIDASE II, HUMAN; ISOPROTEIN; MEMBRANE ANTIGEN; MITOGENIC AGENT; PROTEIN KINASE P60; SH2B2 PROTEIN, HUMAN; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CATALYSIS; CELL MEMBRANE POTENTIAL; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; MITOGENESIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN VARIANT; SRC HOMOLOGY DOMAIN; ANIMAL; CELL LINE; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; ANTIGENS, SURFACE; CATALYSIS; CELL LINE; DROSOPHILA PROTEINS; ENZYME ACTIVATION; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; MICE; MITOGENS; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS PP60(C-SRC); SRC-FAMILY KINASES; STAT3 TRANSCRIPTION FACTOR;

EID: 46449132431     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21606     Document Type: Article

References (72)

1. Ahmed Z, Pillay TS. 2001. Functional effects of APS and SH2-B on insulin receptor signalling. Biochem Soc Trans 29:529-534.
2. Ahmed Z, Pillay TS. 2003. Adapter protein with a pleckstrin homology (PH) and an Src homology 2 (SH2) domain (APS) and SH2-B enhance insulin-receptor autophosphorylation, extracellular-signal-regulated kinase and phosphoinositide 3-kinase-dependent signalling. Biochem J 371:405-412.
3. Bromann PA, Korkaya H, Courtneidge SA. 2004. The interplay between Src family kinases and receptor tyrosine kinases. Oncogene 23:7957-7968.
4. Bromberg J, Darnell JE, Jr. 2000. The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19:2468-2473.
5. Bromberg JF, Horvath CM, Besser D, Lathem WW, Darnell JE, Jr. 1998. Stat3 activation is required for cellular transformation by v-src. Mol Cell Biol 18:2553-2558.
6. Cao X, Tay A, Guy GR, Tan YH. 1996. Activation and association of Stat3 with Src in v-Src-transformed cell lines. Mol Cell Biol 16:1595-1603.
7. Carter-Su C, Rui L, Herrington J. 2000a. Role of the tyrosine kinase JAK2 in signal transduction by growth hormone. Pediatr Nephrol 14:550-557.
8. Carter-Su C, Rui L, Stofega MR. 2000b. SH2-B and SIRP: JAK2 binding proteins that modulate the actions of growth hormone. Recent Prog Horm Res 55:293-311.
9. Chen L, Carter-Su C. 2004. Adapter protein SH2-B beta undergoes nucleocytoplasmic shuttling: Implications for nerve growth factor induction of neuronal differentiation. Mol Cell Biol 24:3633-3647.
10. Darnell JE, Jr. 1997. STATs and gene regulation. Science 277:1630-1635.
11. Deng Y, Xu H, Riedel H. 2007. PSM/SH2-B distributes selected mitogenic receptor signals to distinct components in the PI3-kinase and MAP kinase signaling pathways. J Cell Biochem 100:557-573.
12. Dhe-Paganon S, Werner ED, Nishi M, Hansen L, Chi YI, Shoelson SE. 2004. A phenylalanine zipper mediates APS dimerization. Nat Struct Mol Biol 11:968-974.
13. Diakonova M, Gunter DR, Herrington J, Carter-Su C. 2002. SH2-Bbeta is a Rac-binding protein that regulates cell motility. J Biol Chem 277:10669-10677.
14. Donatello S, Fiorino A, Degl'innocenti D, Alberti L, Miranda C, Gorla L, Bongarzone I, Rizzetti MG, Pierotti MA, Borrello MG. 2007. SH2B1beta adaptor is a key enhancer of RET tyrosine kinase signaling. Oncogene 26:6546-6559.
15. Duan C, Li M, Rui L. 2004a. SH2-B promotes insulin receptor substrate 1 (IRS1)- and IRS2-mediated activation of the phosphatidylinositol 3-kinase pathway in response to leptin. J Biol Chem 279:43684-43691.
16. Duan C, Yang H, White MF, Rui L. 2004b. Disruption of the SH2-B gene causes age-dependent insulin resistance and glucose intolerance. Mol Cell Biol 24:7435-7443.
17. Eggert A, Ikegaki N, Liu X, Chou TT, Lee VM, Trojanowski JQ, Brodeur GM. 2000. Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells. Oncogene 19:2043-2051.
18. Garcia R, Bowman TL, Niu G, Yu H, Minton S, Muro-Cacho CA, Cox CE, Falcone R, Fairclough R, Parsons S, Laudano A, Gazit A, Levitzki A, Kraker A, Jove R. 2001. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 20:2499-2513.
19. Hayakawa F, Naoe T. 2006. SFK-STAT pathway: An alternative and important way to malignancies. Ann NY Acad Sci 1086:213-222.
20. Herrington J, Diakonova M, Rui L, Gunter DR, Carter-Su C. 2000. SH2-B is required for growth hormone-induced actin reorganization. J Biol Chem 275:13126-13133.
21. Hu J, Hubbard SR. 2006. Structural basis for phosphotyrosine recognition by the Src homology-2 domains of the adapter proteins SH2-B and APS. J Mol Biol 361:69-79.
22. Huang X, Li Y, Tanaka K, Moore KG, Hayashi JI. 1995. Cloning and characterization of Lnk, a signal transduction protein that links T-cell receptor activation signal to phospholipase C gamma 1, Grb2, and phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA 92:11618-11622.
23. Iseki M, Takaki S, Takatsu K. 2000. Molecular cloning of the mouse APS as a member of the Lnk family adaptor proteins. Biochem Biophys Res Commun 272:45-54.
24. Jamshidi Y, Snieder H, Ge D, Spector TD, O'Dell SD. 2007. The SH2B gene is associated with serum leptin and body fat in normal female twins. Obesity (Silver Spring) 15:5-9.
25. Johnson PJ, Coussens PM, Danko AV, Shalloway D. 1985. Overexpressed pp60c-src can induce focus formation without complete transformation of NIH 3T3 cells. Mol Cell Biol 5:1073-1083.
26. Johnson D, Agochiya M, Samejima K, Earnshaw W, Frame M, Wyke J. 2000. Regulation of both apoptosis and cell survival by the v-Src oncoprotein. Cell Death Differ 7:685-696.
27. Koch A, Mancini A, Stefan M, Niedenthal R, Niemann H, Tamura T. 2000. Direct interaction of nerve growth factor receptor, TrkA, with non-receptor tyrosine kinase, c-Abl, through the activation loop. FEBS Lett 469:72-76.
28. Kong M, Wang CS, Donoghue DJ. 2002. Interaction of fibroblast growth factor receptor 3 and the adapter protein SH2-B. A role in STAT5 activation. J Biol Chem 277:15962-15970.
29. Kotani K, Wilden P, Pillay TS. 1998. SH2-Balpha is an insulin-receptor adapter protein and substrate that interacts with the activation loop of the insulin-receptor kinase. Biochem J 335(Pt 1):103-109.
30. Kubo-Akashi C, Iseki M, Kwon SM, Takizawa H, Takatsu K, Takaki S. 2004. Roles of a conserved family of adaptor proteins, Lnk, SH2-B, and APS, for mast cell development, growth, and functions: APS-deficiency causes augmented degranulation and reduced actin assembly. Biochem Biophys Res Commun 315:356-362.
31. Kurzer JH, Argetsinger LS, Zhou YJ, Kouadio JL, O'Shea JJ, Carter-Su C. 2004. Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-B beta. Mol Cell Biol 24:4557-4570.
32. Kurzer JH, Saharinen P, Silvennoinen O, Carter-Su C. 2006. Binding of SH2-B family members within a potential negative regulatory region maintains JAK2 in an active state. Mol Cell Biol 26:6381-6394.
33. Li M, Ren D, Iseki M, Takaki S, Rui L. 2006. Differential role of SH2-B and APS in regulating energy and glucose homeostasis. Endocrinology 147:2163-2170.
34. Li M, Li Z, Morris DL, Rui L. 2007. Identification of SH2B2{beta} as an Inhibitor for SH2B1- and SH2B2{alpha}-promoted JAK2 activation and insulin signaling. Endocrinology 148:1615-1628.
35. Maures TJ, Kurzer JH, Carter-Su C. 2006. SH2B1 (SH2-B) and JAK2: A multifunctional adaptor protein and kinase made for each other. Trends Endocrinol Metab.
36. Minami A, Iseki M, Kishi K, Wang M, Ogura M, Furukawa N, Hayashi S, Yamada M, Obata T, Takeshita Y, Nakaya Y, Bando Y, Izumi K, Moodie SA, Kajiura F, Matsumoto M, Takatsu K, Takaki S, Ebina Y. 2003. Increased insulin sensitivity and hypoinsulinemia in APS knockout mice. Diabetes 52:2657-2665.
37. Miquet JG, Sotelo AI, Bartke A, Turyn D. 2005. Increased SH2-Bbeta content and membrane association in transgenic mice overexpressing GH. J Endocrinol 185:301-306.
38. Moodie SA, Alleman-Sposeto J, Gustafson TA. 1999. Identification of the APS protein as a novel insulin receptor substrate. J Biol Chem 274:11186-11193.
39. Nelms K, O'Neill TJ, Li S, Hubbard SR, Gustafson TA, Paul WE. 1999. Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain. Mamm Genome 10:1160-1167.
40. Nishi M, Werner ED, Oh BC, Frantz JD, Dhe-Paganon S, Hansen L, Lee J, Shoelson SE. 2005. Kinase activation through dimerization by human SH2-B. Mol Cell Biol 25:2607-2621.
41. Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, Jove R, Yu H. 2002. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21:2000-2008.
42. O'Brien KB, O'Shea JJ, Carter-Su C. 2002. SH2-B family members differentially regulate JAK family tyrosine kinases. J Biol Chem 277:8673-8681.
43. O'Brien KB, Argetsinger LS, Diakonova M, Carter-Su C. 2003. YXXL motifs in SH2-Bbeta are phosphorylated by JAK2, JAK1, and platelet-derived growth factor receptor and are required for membrane ruffling. J Biol Chem 278:11970-11978.
44. Odajima J, Matsumura I, Sonoyama J, Daino H, Kawasaki A, Tanaka H, Inohara N, Kitamura T, Downward J, Nakajima K, Hirano T, Kanakura Y. 2000. Full oncogenic activities of v-Src are mediated by multiple signaling pathways. Ras as an essential mediator for cell survival. J Biol Chem 275:24096-24105.
45. Ohtsuka S, Takaki S, Iseki M, Miyoshi K, Nakagata N, Kataoka Y, Yoshida N, Takatsu K, Yoshimura A. 2002. SH2-B is required for both male and female reproduction. Mol Cell Biol 22:3066-3077.
46. Osborne MA, Dalton S, Kochan JP. 1995. The yeast tribrid system - Genetic detection of trans-phosphorylated ITAM-SH2-interactions. Biotechnology (NY) 13:1474-1478.
47. Qian X, Ginty DD. 2001. SH2-B and APS are multimeric adapters that augment TrkA signaling. Mol Cell Biol 21:1613-1620.
48. Qian X, Riccio A, Zhang Y, Ginty DD. 1998. Identification and characterization of novel substrates of Trk receptors in developing neurons. Neuron 21:1017-1029.
49. Ren D, Zhou Y, Morris D, Li M, Li Z, Rui L. 2007. Neuronal SH2B1 is essential for controlling energy and glucose homeostasis. J Clin Invest 117:397-406.
50. Riedel H, Wang J, Hansen H, Yousaf N. 1997. PSM, an insulin-dependent, pro-rich, PH, SH2 domain containing partner of the insulin receptor. J Biochem (Tokyo) 122:1105-1113.
51. Riedel H, Yousaf N, Zhao Y, Dai H, Deng Y, Wang J. 2000. PSM, a mediator of PDGF-BB-, IGF-I-, and insulin-stimulated mitogenesis. Oncogene 19:39-50.
52. Riley D, Carragher NO, Frame MC, Wyke JA. 2001. The mechanism of cell cycle regulation by v-Src. Oncogene 20:5941-5950.
53. Rudd CE. 2001. Lnk adaptor: Novel negative regulator of B cell lymphopoiesis. Sci STKE 85:PE1.
54. Rui L, Carter-Su C. 1998. Platelet-derived growth factor (PDGF) stimulates the association of SH2-Bbeta with PDGF receptor and phosphorylation of SH2-Bbeta. J Biol Chem 273:21239-21245.
55. Rui L, Carter-Su C. 1999. Identification of SH2-bbeta as a potent cytoplasmic activator of the tyrosine kinase Janus kinase 2. Proc Natl Acad Sci USA 96:7172-7177.
56. Rui L, Mathews LS, Hotta K, Gustafson TA, Carter-Su C. 1997. Identification of SH2-Bbeta as a substrate of the tyrosine kinase JAK2 involved in growth hormone signaling. Mol Cell Biol 17:6633-6644.
57. Rui L, Herrington J, Carter-Su C. 1999. SH2-B, a membrane-associated adapter, is phosphorylated on multiple serines/threonines in response to nerve growth factor by kinases within the MEK/ERK cascade. J Biol Chem 274:26485-26492.
58. Rui L, Gunter DR, Herrington J, Carter-Su C. 2000. Differential binding to and regulation of JAK2 by the SH2 domain and N-terminal region of SH2-bbeta. Mol Cell Biol 20:3168-3177.
59. Schlessinger K, Levy DE. 2005. Malignant transformation but not normal cell growth depends on signal transducer and activator of transcription 3. Cancer Res 65:5828-5834.
60. Silva CM. 2004. Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis. Oncogene 23:8017-8023.
61. Suzuki K, Mizutani M, Hitomi Y, Kizaki T, Ohno H, Ishida H, Haga S, Koizumi S. 2002. Association of SH2-B to phosphorylated tyrosine residues in the activation loop of TrkB. Res Commun Mol Pathol Pharmacol 111:27-39.
62. Turkson J, Bowman T, Garcia R, Caldenhoven E, De Groot RP, Jove R. 1998. Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol Cell Biol 18:2545-2552.
63. Velazquez L, Cheng AM, Fleming HE, Furlonger C, Vesely S, Bernstein A, Paige CJ, Pawson T. 2002. Cytokine signaling and hematopoietic homeostasis are disrupted in Lnk-deficient mice. J Exp Med 195:1599-1611.
64. Wadia JS, Dowdy SF. 2005. Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer. Adv Drug Deliv Rev 57:579-596.
65. Wang J, Riedel H. 1998. Insulin-like growth factor-I receptor and insulin receptor association with a Src homology-2 domain-containing putative adapter. J Biol Chem 273:3136-3139.
66. Wang X, Chen L, Maures TJ, Herrington J, Carter-Su C. 2004. SH2-B is a positive regulator of nerve growth factor-mediated activation of the Akt/Forkhead pathway in PC12 cells. J Biol Chem 279:133-141.
67. Westhoff MA, Serrels B, Fincham VJ, Frame MC, Carragher NO. 2004. SRC-mediated phosphorylation of focal adhesion kinase couples actin and adhesion dynamics to survival signaling. Mol Cell Biol 24:8113-8133.
68. Yokouchi M, Suzuki R, Masuhara M, Komiya S, Inoue A, Yoshimura A. 1997. Cloning and characterization of APS, an adaptor molecule containing PH and SH2 domains that is tyrosine phosphorylated upon B-cell receptor stimulation. Oncogene 15:7-15.
69. Yoshiga D, Sato N, Torisu T, Mori H, Yoshida R, Nakamura S, Takaesu G, Kobayashi T, Yoshimura A. 2007. Adaptor protein SH2-B linking receptor-tyrosine kinase and Akt promotes adipocyte differentiation by regulating PPAR {gamma} mRNA levels. Mol Endocrinol 21:1120-1131.
70. Yousaf N, Deng Y, Kang Y, Riedel H. 2001. Four PSM/SH2-B alternative splice variants and their differential roles in mitogenesis. J Biol Chem 276:40940-40948.
71. Zhang Y, Turkson J, Carter-Su C, Smithgall T, Levitzki A, Kraker A, Krolewski JJ, Medveczky P, Jove R. 2000. Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activity. J Biol Chem 275:24935-24944.
72. Zhang M, Deng Y, Tandon R, Bai C, Riedel H. 2007. Essential role of PSM/SH2-B variants in insulin receptor catalytic activation and the resulting cellular responses. J Cell Biochem. Published online: 5 July 2007.